Novel approaches to female sexual dysfunction

被引:13
作者
Berman, LA [1 ]
Berman, JR [1 ]
Chhabra, S [1 ]
Goldstein, I [1 ]
机构
[1] Boston Univ, Med Ctr, Div Urol, Boston, MA 02215 USA
关键词
apomorphine; female pelvic anatomy; female sexual disorders; female sexual dysfunction; L-arginine; methyltestosterone; neurogenic mediators; oestrogen; phentolamine; prostaglandin E1; sildenafil; testosterone; yohimbine;
D O I
10.1517/13543784.10.1.85
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Female sexual dysfunction is age-related, progressive and highly prevalent, affecting 30 - 50% of American women. While there are emotional and relational elements to sexual function, it has become increasingly evident that female sexual dysfunction can occur secondary to medical problems and has an organic basis. A plethora of different female sexual dysfunctions exist and in order to obtain a greater understanding of the possible treatments for these problems, it is essential to have a strong knowledge base of female pelvic anatomy, the neurogenic mediators of female sexual response, the impact of hormones on female sexual function and the aetiologies of female sexual dysfunction. Currently, there are potential therapeutic options for the treatment of female sexual dysfunction and these options include both hormonal and pharmacological therapy. However, therapeutic agents may not prove to be enough and the ideal approach to female sexual dysfunction is thus a collaborative effort between therapists and physicians, which should include a complete medical and psychosocial evaluation, as well as inclusion of the partner or spouse in the evaluation and treatment process.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 32 条
[1]   Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina [J].
Berman, JR ;
McCarthy, MM ;
Kyprianou, N .
UROLOGY, 1998, 51 (04) :650-656
[2]   Female sexual dysfunction: Incidence, pathophysiology, evaluation, and treatment options [J].
Berman, JR ;
Berman, L ;
Goldstein, I .
UROLOGY, 1999, 54 (03) :385-391
[3]   Clinical evaluation of female sexual function: effects of age and estrogen status on subjective and physiologic sexual responses [J].
Berman, JR ;
Berman, LA ;
Werbin, TJ ;
Flaherty, EE ;
Leahy, NM ;
Goldstein, I .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1999, 11 (Suppl 1) :S31-S38
[4]  
BERMAN JR, IN PRESS J SEX MARIT
[5]   Outcomes of hysterectomy [J].
Carlson, KJ .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1997, 40 (04) :939-946
[6]  
Goldstein I, 1998, INT J IMPOT RES, V10, pS84
[7]  
GRAZIOTTIN A, 1996, YB ROYAL COLL OBSTET, P235
[8]   VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE HUMAN FEMALE REPRODUCTIVE-TRACT - DISTRIBUTION AND MOTOR EFFECTS [J].
HELM, G ;
OTTESEN, B ;
FAHRENKRUG, J ;
LARSEN, JJ ;
OWMAN, C ;
SJOBERG, NO ;
STOLBERG, B ;
SUNDLER, F ;
WALLES, B .
BIOLOGY OF REPRODUCTION, 1981, 25 (01) :227-234
[9]  
Hoyle CHV, 1996, J ANAT, V188, P633
[10]   SEXUAL DYSFUNCTION WITH AGING AND SYSTEMIC HYPERTENSION [J].
HSUEH, WA .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (16) :H18-H23